EcoDrugPlus

Ensembl ID : ENSATEG00000007293
Gene Symbol: -
Cross references: -
163 Possible Orthologues:

Ensembl ID : ENSATEG00000003862
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSATEG00000011760
Gene Symbol: -
Cross references: -
556 Possible Orthologues:

Ensembl ID : ENSATEG00000003363
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSATEG00000003191
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSATEG00000010117
Gene Symbol: -
Cross references: -
228 Possible Orthologues:

Ensembl ID : ENSATEG00000011806
Gene Symbol: -
Cross references: -
556 Possible Orthologues:

Ensembl ID : ENSATEG00000010984
Gene Symbol: -
Cross references: -
204 Possible Orthologues:

Ensembl ID : ENSATEG00000011819
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSATEG00000011831
Gene Symbol: -
Cross references: -
348 Possible Orthologues:

Ensembl ID : ENSATEG00000011865
Gene Symbol: -
Cross references: -
349 Possible Orthologues:

Ensembl ID : ENSATEG00000001100
Gene Symbol: -
Cross references: -
175 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).